Admission Blood Glucose in the Emergency Department is Associated with Increased In-Hospital Mortality in Nontraumatic Critically Ill Patients



      Abnormal admission blood glucose was reported as a useful predictor of outcome in critically ill patients.


      To identify patients at higher risk, this study aimed to evaluate the relationship between admission blood glucose levels and patient mortality during the management of nontraumatic critically ill patients in the emergency department (ED).


      In this prospective, single-center observational study in a German university ED, all adult patients admitted to the resuscitation room of the ED were included between September 1, 2014 and August 31, 2015. Directly after resuscitation room admission, blood samples for admission blood glucose were taken, and adult patients were divided into groups according to predefined cut-offs between the admission blood glucose. Study endpoint was in-hospital mortality.


      During the study period, 532 patients were admitted to the resuscitation room. The data of 523 patients (98.3%) were available for analysis. The overall in-hospital mortality was 34.2%. In comparison with an in-hospital mortality of 25.2% at an admission blood glucose of 101–136 mg/dL (n = 107), admission blood glucose of ≤ 100 mg/dL (n = 25, odds ratio [OR] 6.30, 95% confidence interval [CI] 2.44–16.23, p < 0.001), 272–361 mg/dL (n = 63, OR 2.53, 95% CI 1.31–4.90, p = 0.007), and ≥ 362 mg/dL (n = 44, OR 2.96, 95% CI 1.42–6.18, p = 0.004) were associated with a higher mortality.


      Abnormal admission blood glucose is associated with a high in-hospital mortality. Admission blood glucose is an inexpensive and rapidly available laboratory parameter that may predict mortality and help to identify critically ill patients at risk in a general nontraumatic critically ill ED patient cohort. The breakpoint for in-hospital mortality may be an admission blood glucose ≤ 100 and ≥ 272 mg/dL.


      To read this article in full you will need to make a payment


        • Bernhard M
        • Döll S
        • Hartwig T
        • et al.
        Resuscitation room management of critically ill non-traumatic-patients in a German emergency department (OBSERvE-Study).
        Eur J Emerg Med. 2018; 25: e9-e17
        • Martin WG
        • Galligan J
        • Simpson S
        • et al.
        Admission blood glucose predicts mortality and length of stay in patients admitted through the emergency department.
        Intern Med J. 2015; 45: 916-924
        • Lipton JA
        • Barendse RJ
        • Van Domburg RT
        • et al.
        Hyperglycemia at admission and during hospital stay are independent risk factors for mortality in high risk cardiac patients admitted to an intensive cardiac care unit.
        Eur Heart J Acute Cardiovasc Care. 2013; 2: 306-313
        • Dungan KM
        • Braithwaite SS
        • Preiser JC.
        Stress hyperglycaemia.
        Lancet. 2009; 373: 1798-1807
        • Inzucchi SE.
        Clinical practice. Management of hyperglycemia in the hospital setting.
        N Engl J Med. 2006; 355: 1903-1911
        • Plummer MP
        • Bellomo R
        • Cousins CE
        • et al.
        Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality.
        Intensive Care Med. 2014; 40: 973-980
        • Kataja A
        • Tarvasmaki T
        • Lassus J
        • et al.
        The association of admission blood glucose level with the clinical picture and prognosis in cardiogenic shock – results from the CardShock Study.
        Int J Cardiol. 2017; 226: 48-52
        • Barth E
        • Albuszies G
        • Baumgart K
        • et al.
        Glucose metabolism and catecholamines.
        Crit Care Med. 2007; 35: S508-S518
        • Preiser JC
        • Ichai C
        • Orban JC
        • Groeneveld AB.
        Metabolic response to the stress of critical illness.
        Br J Anaesth. 2014; 113: 945-954
        • Björk M
        • Melin EO
        • Frisk T
        • Thunander M.
        Admission glucose level was associated with increased short-term mortality and length-of-stay irrespective of diagnosis, treating medical specialty or concomitant laboratory values.
        Eur J Intern Med. 2020; 75: 71-78
        • Kreutziger J
        • Schlaepfer J
        • Wenzel V
        • Constantinescu MA.
        The role of admission blood glucose in outcome prediction of surviving patients with multiple injuries.
        J Trauma. 2009; 67: 704-708
        • Kreutziger J
        • Wenzel V
        • Kurz A
        • Constantinescu MA.
        Admission blood glucose is an independent predictive factor for hospital mortality in polytraumatised patients.
        Intensive Care Med. 2009; 35: 1234-1239
        • Kreutziger J
        • Rafetseder A
        • Mathis A
        • et al.
        Admission blood glucose predicted haemorrhagic shock in multiple trauma patients.
        Injury. 2015; 46: 15-20
        • Petersen JR
        • Graves DF
        • Tacker DH
        • et al.
        Comparison of POCT and central laboratory blood glucose results using arterial, capillary, and venous samples from MICU patients on tight glycemic control.
        Clin Chim Acta. 2008; 396: 10-13
        • Kushimoto S
        • Abe T
        • Ogura H
        • et al.
        Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: an analysis from a multicenter, prospective survey of severe sepsis.
        PLoS One. 2020; 15e0229919
        • Bochicchio GV
        • Joshi M
        • Bochicchio KM
        • et al.
        Early hyperglycemic control is important in critically injured trauma patients.
        J Trauma. 2007; 63: 1353-1358
        • Freire AX
        • Bridges L
        • Umpierrez GE
        • Kuhl D
        • Kitabchi AE.
        Admission hyperglycemia and other risk factors as predictors of hospital mortality in a medical ICU population.
        Chest. 2005; 128: 3109-3116
        • Krinsley JS.
        Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.
        Mayo Clin Proc. 2003; 78: 1471-1478
        • Taylor JH
        • Beilman GJ.
        Hyperglycemia in the intensive care unit: no longer just a marker of illness severity.
        Surg Infect. 2005; 6: 233-245
        • Vogelzang M
        • Nijboer JM
        • van der Horst IC
        • et al.
        Hyperglycemia has a stronger relation with outcome in trauma patients than in other critically ill patients.
        J Trauma. 2006; 60: 873-877
        • Hermanides J
        • Bosman RJ
        • Vriesendorp TM
        • et al.
        Hypoglycemia is associated with intensive care unit mortality.
        Crit Care Med. 2010; 38: 1430-1434
        • Lepper PM
        • Ott S
        • Nuesch E
        • et al.
        Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study.
        BMJ. 2012; 344: e3397
        • Finfer S
        • Liu B
        • Chittock DR
        • et al.
        Hypoglycaemia and risk of death in critically ill patients.
        N Engl J Med. 2012; 367: 1108-1118
        • The NICE-SUGAR Study Investigators
        Intensive versus conventional glucose control in critically ill patients.
        N Engl J Med. 2009; 360: 1283-1297
        • Lenderink T
        • Hernandez AV
        • Boersma E
        • et al.
        Prediction of 30-day mortality in older patients with a first acute myocardial infarction.
        Cardiology. 2010; 115: 1-9
        • Kim SH
        • Park KN
        • Choi SP
        • et al.
        Time to reach target glucose level and outcome after cardiac arrest patients treated with therapeutic hypothermia.
        J Crit Care. 2015; 30: 1204-1209